<scp>AZP2006</scp> in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open‐Label Extension on Safety, Biomarkers, and Disease Progression

AZP2006 was well-tolerated and demonstrated favorable trends in biomarker and clinical outcomes. These preliminary signals support further investigation to determine whether a meaningful clinical benefit can be achieved in PSP with AZP2006. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-09-27
DOI
https://doi.org/10.1002/mds.70049
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AZP2006 in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open‐Label Extension on Safety, Biomarkers, and Disease Progression

Nicolas Carrière, Jean‐Christophe Corvol, Philippe Verwaerde, Olivier Defert et al.
Movement Disorders
Parkinson's Disease Mechanisms and Treatments
article

AZP2006 in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open‐Label Extension on Safety, Biomarkers, and Disease Progression

Nicolas Carrière, Jean‐Christophe Corvol, Philippe Verwaerde, Olivier Defert, Cecilia Estrella, Mickaël Alexandre Obadia, Luc Defebvre, David Devos, Graziella Mangone, Noëlle Callizot, Günter U. Höglinger, Aurélien Blondel, Louise‐Laure Mariani, Caroline Moreau, Artin Karapet, Jean‐Philippe Brandel, Sara Sambin, Marie Lebouteux
article en

Abstract

AZP2006 was well-tolerated and demonstrated favorable trends in biomarker and clinical outcomes. These preliminary signals support further investigation to determine whether a meaningful clinical benefit can be achieved in PSP with AZP2006. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Movement DisordersVol. 40(12)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Munich Cluster for Systems Neurology (DE), Fondation Ophtalmologique Adolphe de Rothschild (FR), Fondation de Rothschild (FR), Institut de Psychiatrie et Neurosciences de Paris (FR), Institut du Cerveau (FR), Ludwig-Maximilians-Universität München (DE), Evotec (United States) (US)
Openalex Percentile: Top 62%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.